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Antibody Response in Snakes with Boid Inclusion Body Disease 
Boid Inclusion Body disease (BIBD) is a fatal disease of captive boid snakes caused by 
reptarenavirus (RAV) infection. BIBD-positive snakes often die of secondary infections, 
suggesting immunosuppression. However, knowledge on the reptile immune system is sparse 
and in particular the response to RAV infection is unknown. The present study investigated a 
colony of 70 Boa constrictor snakes for BIBD (presence of pathognomonic inclusion bodies 
(IB) in blood cells in blood smears), RAV viraemia, anti-RAV IgM and IgY and population 
parameters, mainly to evaluate serology as a diagnostic tool. By next generation sequencing 
and reverse transcriptase-polymerase chain reaction (RT-PCR) on pooled blood samples of 
snakes with and without BIBD, three RAV S segments were identified. RT-PCRs on all blood 
samples showed a strong correlation between the presence of University of Giessen Virus 
(UGV) S segment and BIBD. A negative correlation between BIBD and the presence of anti-
UGV NP IgY antibodies, and an association of lower anti-RAV antibody levels with BIBD 
provide evidence of immunosuppression. Also, female snakes had a significantly lower body 
weight when BIBD-positive. In summary the detection of UGV S segment and the presence of 
anti-RAV IgY antibodies might predict the development of BIBD, however serology per se 
cannot replace cytology as the current gold standard for intra vitam diagnosis of BIBD. 
Keywords: Boid Inclusion Body Disease (BIBD), Reptarenavirus, antibodies, immune 
response, serology 
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Antikörperantwort in Schlangen mit Boid Inclusion Body Disease 
Boid Inclusion Body Disease (BIBD) ist eine durch Reptarenaviren (RAV) verursachte, 
häufig tödlich verlaufende Erkrankung der Boiden. Hinweisend auf eine Immunsuppression 
durch BIBD erliegen betroffene Tiere oft Sekundärinfektionen. Bisher ist wenig über das 
Immunsystem der Reptilien und speziell zur Reaktion auf eine RAV-Infektion bekannt. Die 
vorliegende Studie untersucht Blutproben von 70 Boa constrictor-Schlangen eines Bestandes 
auf das Vorkommen pathognomonischer Einschlusskörperchen, RAV-Virämie, auf anti-RAV 
Antikörper (IgM, IgY) und Populationsparameter, um den diagnostischen Nutzen der 
Serologie zu beurteilen. Mittels Next generation sequencing und reverse Transkription-
Polymerase-Kettenreaktion (RT-PCR) an Poolproben von Tieren mit und ohne BIBD wurden 
drei RAV S-Segmente identifiziert. RT-PCRs der Einzeltiere zeigten eine deutliche 
Korrelation des University of Giessen Virus (UGV) S-Segments mit BIBD. Eine negative 
Korrelation zwischen BIBD und anti-UGV NP IgY sowie die niedrigeren anti-RAV 
Antikörpertiter BIBD-positiver Tiere weisen auf eine Immunsuppression durch BIBD hin. 
Weiterhin hatten weibliche BIBD-positive Tiere ein signifikant niedrigeres Körpergewicht. 
Die Resultate zeigen einen möglichen Nutzen des Nachweises von UGV S-Segment und anti-
RAV IgY Antikörpern für Aussagen zur Entwicklung von BIBD. Die serologische 
Untersuchung per se ersetzt jedoch nicht die zytologische intra-vitam Diagnostik. 
Stichwörter: Boid Inclusion Body Disease (BIBD), Reptarenavirus, Antikörper, 
Immunantwort, Serologie 
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Boid Inclusion Body Disease (BIBD) is a potentially fatal disease reported in captive boid 
snakes worldwide that is caused by reptarenavirus infection. Although the detection of intra- 
cytoplasmic inclusion bodies (IB) in blood cells serves as the gold standard for the ante mor- 
tem diagnosis of BIBD, the mechanisms underlying IB formation and the pathogenesis of 
BIBD are unknown. Knowledge on the reptile immune system is sparse compared to the 
mammalian counterpart, and in particular the response towards reptarenavirus infection is 
practically unknown. Herein, we investigated a breeding collection of 70 Boa constrictor 
snakes for BIBD, reptarenavirus viraemia, anti-reptarenavirus IgM and IgY antibodies, and 
population parameters. Using NGS and RT-PCR on pooled blood samples of snakes with 
and without BIBD, we could identify three different reptarenavirus S segments in the collec- 
tion. The examination of individual samples by RT-PCR indicated that the presence of Uni- 
versity of Giessen virus (UGV)-like S segment strongly correlates with IB formation. We 
could also demonstrate a negative correlation between BIBD and the presence of anti-UGV 
NP IgY antibodies. Further evidence of an association between antibody response and 
BIBD is the finding that the level of anti-reptarenavirus antibodies measured by ELISA was 
lower in snakes with BIBD. Furthermore, female snakes had a significantly lower body 
weight when they had BIBD. Taken together our findings suggest that the detection of the 
UGV-/S6-like S segment and the presence of anti-reptarenavirus IgY antibodies might 
serve as a prognostic tool for predicting the development of BIBD. 
 
 
 
 
 
Introduction 
Boid inclusion body disease (BIBD) is a widespread disease of captive boid snakes known 
since the 1970s [1–3]. The disease is characterised by the presence of eosinophilic and 
Antibodies in BIBD 
PLOS ONE | https://doi.org/10.1371/journal.pone.0221863 September 9, 2019 7 
 
 
 
collection and analysis, decision to publish, or 
preparation of the manuscript. 
Competing interests: The authors have declared 
that no competing interests exist. 
electron-dense intracytoplasmic inclusion bodies (IBs) in most cell types of affected snakes [1– 
3]. In the early 2010s, we and others identified arenaviruses as the most likely causative agents 
of BIBD, by demonstrating that the IBs consist mainly of arenavirus nucleoprotein [4–7]. The 
causative link was later confirmed by experimental infection of boas and pythons with reptare- 
navirus isolates [8]. The family Arenaviridae in the order Bunyavirales currently comprises 
four genera: Mammarenavirus, Reptarenavirus, Hartmanivirus, and Antennavirus [9]. The are- 
naviruses found in snakes with BIBD belong to the genera Reptarenavirus and Hartmanivirus 
[9]. 
The genome of reptarenaviruses is a bi-segmented single-stranded negative-sense RNA 
with ambisense coding strategy. The small (S) segment encodes the nucleoprotein (NP) and 
the glycoprotein precursor (GPC), while the matrix protein (ZP) and the RNA-dependent 
RNA polymerase (RdRp) are encoded by the large (L) segment [10]. The genome of hartmani- 
viruses is similar, except that it lacks the ZP [10]. Snakes with BIBD are commonly co-infected 
with several reptarenaviruses, and, curiously, they often harbour more L than S segments 
[1,11,12]. The co-existence of multiple segments in an infected snake likely allows re-assort- 
ment of L and S segments [12]. The genetic variation between the known reptarenaviruses is 
tremendous and up to now L segments of approximately 30 different reptarenavirus species 
are known [1,10–12]. The genetic dissimilarity significantly hampers the development of sensi- 
tive “pan-reptarenavirus” RT-PCR tools. Therefore, since the IBs occur in blood cells including 
erythrocytes, IB detection in blood smears represents the current gold standard for ante mor- 
tem BIBD diagnosis [3,13]. However, the presence of IBs does not associate with pathological 
changes or clinical signs, and thus snakes with reptarenavirus infection can remain clinically 
healthy for a long time [4,8]. Subclinical infections together with horizontal and vertical trans- 
mission of reptarenaviruses [1,12] are the likely reasons behind reptarenavirus co-infections 
being rather a rule than an exception in snakes with BIBD. 
Despite the above facts, BIBD appears to be ultimately lethal [1–3]. Clinical features 
observed in snakes with BIBD include neurological signs, regurgitation, anorexia, pneumonia, 
stomatitis, and lymphoproliferative disorders [2,13,14]. The pathogenesis is poorly under- 
stood, however, the fact that bacterial infections and/or neoplastic processes are common in 
snakes with BIBD suggests that the disease is associated with immunosuppression [2–4]. Lym- 
phocytic choriomeningitis virus (LCMV), the prototype arenavirus (genus Mammarenavirus), 
induces immunosuppression by inhibition of type I interferon (IFN-I) production [15–17]. 
The underlying mechanism is prevention of the RIG-I(retinoic acid inducible gene-I)/MAVS 
(mitochondrial antiviral signaling) pathway by the NP of LCMV [10,17]. The IFN-I produc- 
tion is further inhibited by the ZP of LCMV, which enters the nucleus and induces re-localisa- 
tion of promyelocytic leukemia (PML) bodies to the cytoplasm [10,18,19]. Intriguingly, PML 
bodies contribute to tumour suppression which is hampered by their cytoplasmic localisation 
[20], thus the ZP of reptarenaviruses could promote tumourigenesis by such a mechanism. 
Additionally, the ZP of New World arenaviruses prevents the type I IFN response by binding 
to RIG-I [17]. 
Currently, not much is known about the immune response of snakes to reptarenaviruses.  
In fact, the knowledge of the reptile immune response in general is scarce, mainly relying on 
individual studies undertaken on different species [21]. It has been shown that like all verte- 
brates, reptiles mount an innate and adaptive immune response, comprising both humoral  
and cell-mediated factors [21,22]. Like in mammals, the humoral branch of the reptile innate 
immune system relies heavily on antimicrobial peptides and proteins as well as the comple- 
ment pathway [21]. Reptiles have equivalents of interleukins (IL), IFNs and Toll-like receptors 
and can therefore coordinate their immune response, however, in vitro studies show the reptile 
system to be temperature and hormone dependent [21,23–28]. Also, in contrast to mammals 
Antibodies in BIBD 
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with their cytokine-mediated development of fever, snakes are poikilotherm and thus increase 
their body temperature behaviourally by exposing themselves to higher environmental tem- 
peratures as demonstrated by stimulation with bacterial LPS or infection with gram-negative 
bacteria [21,29,30]. 
The adaptive immune response of both mammals and reptiles has a cell-mediated and a 
humoral component. The former is based on T cells, and in reptiles their proliferation depends 
on the seasonal cycle [31–33]. Females show a stronger cell-mediated immunity than males in 
both mammals and reptiles [21,34–36], and in the latter T cell proliferation is stronger in non- 
gravid than in gravid animals [21,36]. In vertebrates, including reptiles, the immunoglobulins 
(Ig) orchestrate the humoral branch of the adaptive immune system. Reptiles produce Igs of 
three classes, IgY, IgM and IgD; the leopard gecko (Eublepharis macularius), for example, also 
produces IgA [21,37]. The reptile IgM is considered as equivalent to IgM of other vertebrates, 
and IgY corresponds to mammalian IgG [22,38]; the molecular features are similar. Depend- 
ing on the snake species IgY may occur in three isotypes, a, b, and c. According to sequence 
analysis, the IgY isotypes of boid snakes differ from those of other snake species but show 
structural similarity to mammalian IgG in that the heavy and light chains are covalently bound 
[37]. In both reptiles and mammals exposure to an infectious agent (or other foreign antigen) 
triggers IgM production approximately within a week [21]. In mammals IgM appears around 
10 days [21] and peaks around 10–14 days post exposure. In reptiles, serum IgM levels reach 
the peak much later, up to 8 weeks post exposure, indicating differences in the maturation of 
the adaptive immune response compared to mammals [14,21]. Depending on the species stud- 
ied and the antigens used, the IgM response in reptiles can last up to 34 weeks after exposure 
[21], whereas the IgY response appears around 31 days post exposure and can last for many 
years, similar to the mammalian IgG response [39]. 
Overall, in comparison to mammals, the reptile antibody response is weaker [22] since the 
titres do not necessarily increase after a second antigen exposure and there is a lack of affinity 
maturation [21,22]. However, studies on colubrid snakes indicated an increase in titres after 
repeated antigen exposure [40], and the rapidness of the response indicates immunological 
memory [21,22,40]. Again, the reptile antibody response is affected by environmental and 
individual factors such as temperature, season, sex, age, and the neuroendocrine status [14,22]. 
We set up this study to assess the antibody response against reptarenaviruses in snakes. Our 
working hypothesis was that snakes with BIBD, i.e. with the presence of IBs in blood cells and 
confirmed reptarenvirus infection, would show low anti-reptarenavirus antibody titres, if any. 
We also wanted to study whether other measurable parameters, such as the sex, age, and 
weight of the animals, or the number of reptarenaviruses infecting an individual snake could 
be associated with IB formation. To answer these questions, we studied a cohort (N = 70) of 
snakes in a single breeding collection with previously confirmed BIBD cases. 
 
Results 
Diagnosis of BIBD based on the cytological examination of blood smears 
We based the BIBD diagnosis on the detection of IBs in cells in blood smears stained with 
May-Gru¨nwald-Giemsa [7]. A similar approach was recently confirmed to correlate well with 
immunological staining of peripheral white blood cells (PWBC) for reptarenavirus NP [41]. 
We confirmed the association of the IBs with reptarenavirus infection by RT-PCR (see below), 
considering this as further proof of the disease and evidence that affected animals will eventu- 
ally develop clinical signs [13]. We could detect IBs (Fig 1) in 34 of the 70 blood smears studied 
(48.57%; BIBD-positive snakes; Table 1). In the remaining 36 snakes (51.43%) the blood cells 
were free of IBs (BIBD-negative snakes; Table 2) [2]. At the time of blood sampling, all but the 
Antibodies in BIBD 
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Fig 1. May-Gru¨nwald-Giemsa stained blood smear, BIBD-positive snake (animal no. 1.25). Erythrocytes frequently 
exhibit intracytoplasmic inclusion bodies (arrows). 
 
https://doi.org/10.1371/journal.pone.0221863.g001 
 
two debilitated snakes and the animal with cloacal prolapse (animals 1.18, 1.20, 1.29) appeared 
clinically healthy. 
We examined the animals’ age and weight against the BIBD diagnosis (Table 3). The aver- 
age age was 4.6 years (95%CI: 4.26–4.99). We did not find statistically significant differences in 
age between female and male animals or between BIBD-positive and -negative animals. How- 
ever, we found a statistically significant (p<0.01) association between BIBD and the weight of 
the female animals: BIBD-positive female animals had significantly lower body weights (Fig 2); 
the geometric mean of the weight was 3.077kg for the BIBD-positive female animals and 4.912 
kg for the negative ones. The same association was not significant for male animals (Table 3). 
Linear regression established that the weight of the animals was significantly associated with 
age, sex and BIBD status (Table 4), F(3,63) = 39.67, and they accounted for 63.74% of weight 
variability. The regression equation is: Predicted Weight = -0.177 + 0.084 age + 0.255 sex— 
0.107 BIBD-positive. 
 
 
 
Characterization of the breeding collection’s “reptarenavirome” 
We and others have previously reported that snakes with BIBD often harbour several reptare- 
navirus L and S segments; usually, more L than S segments are found in each snake [1,11,12]. 
To study whether the BIBD-negative snakes would also be free of reptarenavirus infection, we 
performed a meta-transcriptomic analysis of pooled blood samples (one pool from three 
snakes without evidence of IBs in blood cells, the other from three snakes with a high number 
of IBs in blood cells). From the reads acquired by NGS of the BIBD-positive blood pool we 
could assemble five reptarenavirus L segments and one S segment, as well as two pairs of hart- 
manivirus L and S segments [10]. To our surprise, we could not assemble any full-length L or S 
segments from the reads acquired from the BIBD-negative blood pool. However, using a map- 
ping approach we identified some reads matching the L and S segments assembled from the 
data of the BIBD-positive blood pool. We then decided to screen a further three pools of three 
blood samples by RT-PCR, using virus-specific primers from our earlier study [1], one pool 
from BIBD-negative snakes, two from BIBD-positive snakes. We found the S segments of 
Antibodies in BIBD 
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Table 1. Animals with BIBD included into the study (diagnosis based on the detection of intracytoplasmic inclusion bodies in blood cells, using blood smears). 
 
Animal (number) Age (years) Sex Weight (kg) S segment WB ELISA 
UGV-1 UGV-1 UHV NP UHV NP-C 
UGV-2 S5-like TSMV-2 IgY IgM IgY IgM IgY IgM IgY IgM 
1.01 2 M 1.10 + + + - - - + - - - - 
1.02 2 M 2.10 + + + ++ ++ - + - - - - 
1.03 3 M 1.40 + + + + ++ - - - - - - 
1.04 3 M 1.80 + + - ++ + + + - - - - 
1.05 3 M 3.00 + + - - + - - + - + - 
1.06 3 F 1.00 + + - ++ + - - - - - - 
1.07 3 F 1.50 + - - +++ +++ + + + + + + 
1.08 4 M 1.40 + + + + + - + - - - - 
1.09 4 M 1.60 + + + +++ - - + - - - - 
1.10 4 M 2.20 + + + ++ +++ - - - - - - 
1.11 4 F 2.50 + + - - - - - - - - - 
1.12 4 F 2.60 + + - - - - - - - - - 
1.13 4 F 3.30 + + + + + - - - - - - 
1.14 4 F 3.40 + + - + + - - + + + + 
1.15 4 F 3.40 + + - + - - + - - - - 
1.16 4 F 3.40 + + + + +++ - + - - - - 
1.17 4 F 3.70 + + + - - - - - - - - 
1.18 4 F 3.90 + + + +++ +++ + + + + + + 
1.19 4 F 4.10 + + - + + - - - - - - 
1.20 5 M 0.90 + + + - ++ - + - + - + 
1.21 5 M 1.10 + + + - - - + - - - - 
1.22 5 M 1.60 + + + +++ +++ + + - - + + 
1.23 5 M 2.80 + - - - ++ - + - - - - 
1.24 5 F 1.70 + + + + ++ - - - - - - 
1.25 5 F 2.60 + + + - + - - - - - - 
1.26 5 F 4.50 + + + + ++ - - - - - - 
1.27 6 M 1.80 + + + + + - + - - + - 
1.28 6 M 3.20 + + + - ++ + + - - - + 
1.29 6 F 2.70 + + + ++ - - + - + - + 
1.30 6 F 5.50 + + + +++ +++ + + - + - + 
1.31 7 F 9.00 + + + + + + n.a. - - - - 
1.32 n.a. M 2.40 + + + + + - + + - - + 
1.33 n.a. M 2.70 - + + + - + + + + + + 
1.34 n.a. M 3.10 + + + ++ ++ + - - - - - 
 
n.a.–not available; F–female; M–male; S segment–reptareavirus S segment determined by RT-PCR; WB–Western Blot; Western Blot results graded according to signal 
intensity:—(negative), + (weakly positive), ++ (moderately positive), +++ (strongly positive); ELISA–Enzyme linked immunosorbent assay. 
 
https://doi.org/10.1371/journal.pone.0221863.t001 
 
 
UGV-2, S5-like, and TSMV-2 to be present in the positive pools, while the negative pool was 
only positive for the latter two. The L segment profiles of the pools seemed variable. 
We analysed the population parameters against the RT-PCR test results for associations 
with the detection of hartmaniviruses (OScV-1 and -2). OScV-1 detection did not significantly 
associate with any of the population parameters, while OScV-2 detection positively associated 
with age. The average age of animals without OScV-2 infection was 4.28 years (n = 50, 95%CI: 
Antibodies in BIBD 
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Table 2. Animals without BIBD included into the study (diagnosis based on the detection of intracytoplasmic inclusion bodies in blood cells, using blood smears). 
 
Animal (number) Age (years) Sex Weight (kg) S segment WB ELISA 
UGV-1 UGV-1 UHV NP UHV NP-C 
UGV-2 S5-like TSMV-2 IgY IgM IgY IgM IgY IgM IgY IgM 
2.01 2 M 0.9 - + + ++ + - + + + + + 
2.02 2 M 1.5 - + + ++ +++ - + + - + + 
2.03 2 F 1.3 - + + - + - - - - + + 
2.04 3 M 1.2 - + + +++ ++ + + - - + + 
2.05 3 M 1.3 + + + - - - + + - + + 
2.06 3 M 1.7 - + + + +++ - - - - - - 
2.07 3 M 1.8 - + + - ++ - + - - + - 
2.08 3 F 2.2 - + + - - - + - - - - 
2.09 4 M 2.1 + + + +++ ++ + - + - - - 
2.10 4 M 2.7 + + + +++ +++ - + - + - - 
2.11 4 M 3.3 + + + ++ ++ + - + + + + 
2.12 4 F 3.7 - + + +++ +++ + + + - + + 
2.13 4 F 3.8 - + + ++ ++ + + + + + + 
2.14 4 F 5.8 - + + +++ ++ + + - - - - 
2.15 4 F 6.8 - - - - - - - - - - - 
2.16 5 M 2.2 + + + - - + - + - + + 
2.17 5 M 2.5 - + + + + - - + + + + 
2.18 5 F 5.0 + - + - + + - - - - - 
2.19 5 F 5.3 - + - ++ + + + - - - - 
2.20 5 F 5.3 - - - + - + - - - - - 
2.21 5 F 5.5 - + + ++ - + - + - + + 
2.22 5 F 5.7 - - + ++ - + + + + + + 
2.23 5 F 6.1 - + + +++ + + - + - - - 
2.24 6 M 2.5 + + + - - + - - - - - 
2.25 6 M 3.4 + + + - - + + - - - - 
2.26 6 M 3.5 - + + - + - - - - - - 
2.27 6 F 3.1 - - - +++ +++ + + + + + - 
2.28 6 F 5.6 - + + +++ +++ + - - - - - 
2.29 7 M 3.3 + + - - ++ - - - - - - 
2.30 7 M 4.0 - + + +++ + + - - - - - 
2.31 7 F 5.0 + - + +++ +++ + - + - + - 
2.32 7 F 7.0 - + + +++ +++ + - + + + + 
2.33 7 F 7.5 - + + ++ ++ + + - - - + 
2.34 7 F 10.0 - + + +++ +++ + - + + + + 
2.35 8 M 3.4 - + + +++ + + - + + + + 
2.36 8 F 7.0 - - - +++ ++ + + - - + + 
 
n.a.–not available; F–female; M–male; S segment–reptareavirus S segment determined by RT-PCR; WB–Western Blot; Western Blot results graded according to signal 
intensity:—(negative), + (weakly positive), ++ (moderately positive), +++ (strongly positive); ELISA–Enzyme linked immunosorbent assay. 
 
https://doi.org/10.1371/journal.pone.0221863.t002 
 
 
3.895–4.665), whereas it was 5.647 (n = 17, 95%CI: 40260–4.994) for OScV-2 positive snakes 
(t = -3.498, df: 65, p<0.05). None of the other population parameters showed any associations 
with OScV-2 after controlling for age. OScV-1 and -2 detection showed poor to slight agree- 
ment with the other tests (Cohen’s kappa < 0.2). 
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Table 3. Results of inclusion body detection in blood cells (i.e. diagnosis of BIBD) against population parameters. Univariate analysis and stratification by sex. 
 
 Sex 
(Row%) 
  Weight
(95% CI) 
  Age(n) 
(95% CI) 
 
(Col%)   N = 70   N = 67 
 M F All M F All M F All 
BIBD - 17 19 36 2.238 4.912 3.389 4.588 (17) 5.211 (19) 4.917 (36) 
 (47.22%) (52.78%) (100.00%) (1.788–2.801) (3.919–6.156) (2.767–4.149) (3.643–5.534) (4.464–5.957) (4.343–5.491) 
 (50.00%) (52.78%) (51.43%)       
BIBD 17 17 34 1.876 3.077 2.403 4.071 (14) 4.471 (17) 4.290 (31) 
+ (50.00%) (50.00%) (100.00%) (1.532–2.297) (2.373–3.991) (2.010–2.873) (3.305–4.838) (3.922–5.019) (3.854–4.726) 
 (50.00%) (47.22%) (48.57%)       
All 34 36 70 2.049 3.938 2.867 4.355 (31) 4.861 (36) 4.627 (67) 
 (48.57%) (51.36%) (100.00%) (1.770–2.372) (3.287–4.719) (2.497–3.293) (3.759–4.950) (4.395–5.327) (4.260–4.994) 
 (100.00%) (100.00%) (100.00%)       
 χ2 = 0.054, p = 0.816  t = 1.2365, t = 2.8801, t = 2.5748, t = 0.8785, t = 1.6494, t = 1.7226, 
    df = 32 df = 34 df = 68 df = 29 df = 34 df = 65 
    p = 0.2253 p<0.01 p<0.05 p = 0.3869 p = 0.1083 p = 0.0897 
 
Kg, geometric mean 
Years 
https://doi.org/10.1371/journal.pone.0221863.t003 
 
Detection of reptarenavirus S segments in individual samples by RT-PCRs 
Reptarenaviruses require both segments to make infectious particles; therefore, we applied spe- 
cific RT-PCR for the above identified three S segments to all animals to recognise the reptare- 
navirus infected, viraemic snakes. Of the 70 animals tested, we found 66 (94.3%) to exhibit 
reptarenavirus viraemia. Thirty snakes (42.9%) carried all three S segments examined (UGV-/ 
S6-like, S5-like, and TSMV-2), and 32 (45.7%) carried two S segments. Of these, 21 snakes 
(30%) showed a combination of the S5-like and TSMV-2 S segments, nine snakes (12.9%) had 
the UGV-/S6-like and S5-like S segments, and two snakes (2.9%) had the UGV-/S6-like and 
TSMV-2 S segments. Of the four snakes with a single S segment, we found the UGV-/S6-like S 
segment in two, and the S5-like and TSMV-2 S segment in one snake each. The results are pre- 
sented in detail in Table 1 and are summarised in Table 5. 
We confirmed reptarenavirus viraemia in all BIBD-positive animals, and the majority (23/ 
34; 67.65%) of these snakes carried all three S segments examined (UGV-/S6-like, S5-like, 
TSMV-2). Nine BIBD-positive snakes (26.47%) carried two S segments, and we detected only 
the UGV-/S6-like S segment in the remaining two animals (5.88%; animals 1.07 and 1.23) 
(Tables 1 and 5). The UGV-like S segment was present in BIBD-positive animals. 
In BIBD-negative snakes (N = 36), we found all three viral S segments in seven snakes 
(19.4%), whereas 23 animals (63.9%) carried two S segments, and two snakes (5.56%) had a 
single S segment, one had the S5-like (animal 2.19) and the other the TSMV-2 (animal 2.22) S 
segment. Four snakes (11.1%) were negative for each S segment and deemed to be reptarena- 
virus-free (Tables 1 and 5). 
Substantial agreement was identified between BIBD+ status and UGV-/S6-like S segment 
RT-PCR results (Cohen’s κ = 0.6878). The agreement of the remaining RT-PCR tests with 
BIBD is slight (S5-like κ = 0.1327, TMSV-2 κ = 0.1254, any segment detection κ = 0.183, 
Table 5). Sensitivity and specificity calculations are included in Table 5, though the study was 
not designed for such calculations. 
We examined the associations of the RT-PCR results with population parameters (Table 6). 
Female animals positive for the UGV-/S6-like S segment, as expected given the test agreement 
with the presence of IB, have a significantly lower body weight (t = 2.99624882, df = 34, 
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Fig 2. Association of BIBD, sex and body weight. 
https://doi.org/10.1371/journal.pone.0221863.g002 
 
p<0.05). For male animals the difference in weight is not significant. There is no significant 
difference in the age of UGV-/S6-like S segment RT-PCR-positive and -negative animals or in 
their sex distribution. Multiple linear regression established that the age, sex and a positive 
UGV-/S6-like S segment RT-PCR result are significantly associated with the weight of the ani- 
mals, F (3,63) = 36.98, and they accounted for 62.06% of weight variability. The regression 
equation is: Predicted Weight = -0.287 + 0.089 age + 0.235 sex—0.086 UGV-/S6-like indicating 
that the weight of UGV-/S6-like positive animals is lower than the weight of negative snakes 
after controlling for age and sex. 
 
 
Table 4. Multiple linear regression: Factors associated with weight (Kg log10) (n = 67). 
 
Factors Adjusted b (95% CI) P-value 
Sex (Female) 0.255 (0.178–0.333) < 0.001 
Inclusion detection (positive) -0.107 (-0.185 –- 0.293 < 0.01 
Age (years) 0.084 (0.058–0.110) < 0.001 
Multiple linear regression (AdjR2 = 0.6374). 
 
https://doi.org/10.1371/journal.pone.0221863.t004 
Antibodies in BIBD 
PLOS ONE | https://doi.org/10.1371/journal.pone.0221863 September 9, 2019 14 
 
 
BIBD Total  Sensitivity  
 
 
Table 5. Summary of RT-PCR results including test agreement and sensitivity/specificity with inclusion detection considered the gold standard. 
 
 
 
UGV-2 
 
+ve 
+ve 
33 
-ve 
10 
 
43 
 
κ = 0.688 
(95%CI) 
97.06% 
(95%CI) 
72.22% 
 -ve 1 26 27 (0.524–0.852) (93.10–100)% (61.73–82.71)% 
S5-like +ve 32 29 61 κ = 0.133 94.12% 19.44% 
 -ve 2 7 9 (-0.019–0.284) (88.61–99.63)% (10.17–28.72)% 
TSMV-2 +ve 24 30 54 κ = -0.125 70.59 16.67% 
 -ve 10 6 16 (-0.320–0.069) (59.91–81.26)% (7.94–25.40)% 
Any segment +ve 34 32 66 κ = 0.108 100% 11.11% 
 -ve 0  4 4 (0.005–0.212) (3.75–18.47)% 
Total  34  36 70 
https://doi.org/10.1371/journal.pone.0221863.t005 
 
 
 
Table 6. RT-PCR results against population parameters, univariate analysis including stratification by sex. 
 
 Sex 
(Row%) 
(Col%) 
Weight 
(95% CI) 
N = 70 
Age(n) 
(95% CI) 
N = 67 
 
 M F Total M F Total M F Total 
UGV 10 17 27 2.090 4.901 3.575 4.333 (9) 5.118 (17) 4.846 (26) 
RT-PCR (37.04%) (62.96%) (100.00%) (1.466–2.981) (3.796–6.328) (2.772–4.609) (2.615–6.052) (4.307–5.928) (4.108–5.583) 
-ve (29.41%) (47.22%) (38.57%)       
UGV 24 19 43 2.032 3.238506 2.544208 2.497 4.355 (22) 4.632 (19) 4.488 (41) 
RT-PCR (55.81%) (44.19%) (100.00%) (1.720–2.400) 4.122274 (2.142–2.910) (3.759–4.969) (4.070–5.193) (4.088–4.555) 
+ve (70.59%) (52.78%) (61.43%)       
χ2 = 2.341, p = 0.126 t = 0.1768, t = 2.4882, df = 34 t = 2.622, t = -0.046, t = 1.0597, t = 0.9485, 
 df = 32 
p = 0.8608 
p<0.05 df = 68 
p<0.05 
df = 29 
p = 0.9633 
df = 34 
p = 0.2968 
df = 65 
p = 0.346 
S5-like 1 8 9 2.800 4.497 4.266 5.000 (1) 5.375 (8) 5.333 (9) 
RT-PCR (11.11%) (88.89%) (100.00%)  (2.937–6.884) (2.900–6.275)  (4.039–6.711) (4.180–6.486) 
-ve (2.94%) (22.22%) (12.86%)       
S5-like 33 28 61 2.030 3.792 2.704 4.333 (30) 4.714 (28) 4.517 (58) 
RT-PCR (54.10%) (45.90%) (100.00% (1.748–2.357) (3.070–4.684) (2.336–3.130) (3.718–4.948) (4.210–5.219) (4.126–4.909) 
+ve (97.06%) (77.78%) (87.14%)       
χ2 = 5.8019, p<0.05 t = . . ., df = 32 t = 0.791, df = 34 t = 2.264, t = . . ., df = 29 t = 1.2051, t = 1.528, df = 65 
 p = . . . p = 0.4344 df = 68 
p<0.05 
p = . . . . df = 34 
p = 0.2365 
p = 0.131 
TSMV- 4 12 16 2.658 3.338 3.153 4.500 (4) 4.500 (12) 4.5 (16) 
2 (25.00%) (75.00%) (100.00%) (1.734–4.074) (2.301–4.842) (2.383–4.172) (1.453–7.547) (3.622–5.378) (3.722–5.278) 
RT-PCR 
-ve 
(11.76%) (33.33%) (22.86%)       
TSMV- 30 24 54 1.979 4.278 2.788 4.333 (27) 5.042 (24) 4.667 (51) 
2 (55.56%) (44.44%) (100.00%) (1.688–2.321) (3.464–5.283) (2.368–3.282) (3.694–4.973) (4.395–5.619) (4.236–5.098) 
RT-PCR 
+ve 
(88.24%) (66.67%) (77.14%)       
χ2 = 4.6133, p<0.05 t = 1.3371, t = -1.3264, df = 34 t = 0.743, t = 1.1885, t = -1.1170, t = -0.384, 
 df = 32 
p = 0.1906 
p = 0.1936 df = 68 
p = 0.460 
df = 29 
P = 0.8518 
df = 34 
p = 0.2718 
df = 65 
p = 0.702 
Total 34 36 70 2.049 3.938 2.867 4.355 (31) 4.861 (36) 4.626 (67) 
 (48.57%) (51.43%) (100.00%) (1.770–2.372) (3.287–719) (2.497–3.293) (3.759–4.950) (4.395–5.329) (4.260–4.994) 
 (100.00%) (100.00%) (100.00%)       
 
Kg, geometric mean 
Mean Years 
https://doi.org/10.1371/journal.pone.0221863.t006 
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There is no significant difference in the age of S5-like S segment RT-PCR-positive and -neg- 
ative animals but there are significantly more male positive animals (χ2 = 5.8019, p<0.05). The 
animals’ weight is not significantly associated with a positive S5-like S segment RT-PCR result 
after controlling for sex and age. There is no significant difference in the age of TMSV-2 S seg- 
ment RT-PCR-positive and -negative animals. There are though significantly more male ani- 
mals positive for the TMSV-2 S segment (χ2 = 4.435, p<0.05). The animals’ weight is not 
significantly associated with a positive TMSV-2 S segment RT-PCR result after controlling for 
sex and age. 
Univariate analysis indicated that the number of S segments detected is not significantly 
associated with the age of the animals (ANOVA: F(6,66) = 1.17, p = 0.333). Male animals had 
significantly more S segments (mean = 2.559 [95%CI: 2.236–2.755]) than female animals 
(mean = 1.972 [95%CI:1.664–2.280]), (p<0.01). Linear regression indicates that the number of 
segments is negatively associated with the weight of the animals (F(1,68) = 8.83, R2 = 0.103, 
Predicted weight = 0.696–0.106 number of segments, p<0.01). When the confounding effect 
of sex was examined by stratifying for sex, no significant association was identified between 
the number of S segments and the animals’ weight. There is a positive association between the 
number of segments and the detection of IB in blood cells. The mean number of segments for 
BIBD-positive animals is 2.618 (95%CI: 2.407–2.828) and for BIBD-negative animals 1.917 
(95%CI: 1.632–2.201) (p<0.001). 
 
 
Antibody response against reptarenavirus NP 
So far, not much is known about the antibody response against reptarenaviruses in snakes. In 
our first report on identification of reptarenaviruses in snakes with BIBD, we used an indirect 
ELISA to indicate that there might be antibodies in some snakes with BIBD [7]. In a more 
recent study, we generated tools for the detection of IgM and IgY class antibodies in boas, and, 
using immunofluorescence and western blot, demonstrated that some BIBD-positive snakes 
have antibodies against reptarenavirus NP [14]. 
Antibody detection by western blot (WB). We studied the plasma samples of the entire 
collection using WB as the detection tool, and used concentrated UGV-1 virions as the anti- 
gen. The main protein component of the virions is NP, which is why we interpret the signals 
as anti-NP IgY and IgM. The signal intensities varied and we applied the following grading: 
negative (–), weakly positive (+), moderately positive (++), and strongly positive (+++); the 
WB result for each snake is included in Table 1. Among the 34 BIBD-positive snakes, we 
found five (14.7%) negative for both anti-NP IgY and IgM, whereas 20 snakes (58.8%) had 
both anti-NP IgM and IgY antibodies, and nine (26.5%) had either anti-NP IgY (N = 4) or 
IgM (N = 5). Ten snakes were anti-NP IgY-negative and nine were anti-NP IgM-negative. The 
36 BIBD-negative snakes included 22 (61.1%) anti-NP IgY- and IgM-positive snakes, eight 
(22.2%) were positive for either anti-NP IgY (N = 3) or IgM (N = 5), six (16.7%) were negative 
for both. Eleven snakes were anti-NP IgY-negative and nine anti-NP IgM negative. Within the 
entire collection 11 snakes were negative for both anti-NP IgY and IgM antibodies. There are 
no significant associations of WB results for NP IgY or IgM and any of the population 
parameters. 
The WB results for anti-NP IgY and IgM in relation to BIBD are summarised in Table 7. 
The agreement of the WB results with BIBD is slight for anti-NP IgY (Cohen’s κ = 0.0294) and 
poor for IgM (κ = 0.0000). As for the RT-PCR results we included indicative sensitivity and 
specificity calculations. The sensitivity of the IgY WB in detecting BIBD is 70.6% (95%CI: 
59.8%– 81.4%) and the specificity 32.4% (95%CI:21.2%– 64.3%). For IgM, the WB sensitivity 
is 73.5% (95%CI:63.0% - 84.0%) and the specificity 26.5% (95%CI:16.0% - 37.0%). We 
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Table 7. Results of the detection of IgY and IgM plasma antibodies against UGV-1 virions using WB in comparison to the diseases status (BIBD-positive or–nega- 
tive, based on the presence of cytoplasmic IB in blood cells. 
 
Western blotting   
+ve 
BIBD 
-ve 
 
Total 
Cohen’s κ Sensitivity 
(95%CI) 
Specificity 
(95%CI) 
WB UGV1 IgY +ve 24 25 49 κ = 0.011 70.59% 30.56% 
 -ve 10 11 21 (-0.195–0.218) (59.91–81.26)% (19.76–41.35)% 
WB UGV1 IgM +ve 25 27 52 κ = -0.015 73.53% 25.00% 
-ve 9 9 18 (-0.222–0.193) (63.19–83.86)% (14.86–35.14)% 
Total 34 36 70 
https://doi.org/10.1371/journal.pone.0221863.t007 
 
examined the agreement of the BIBD status against the graded WB results using Cohen’s 
weighted kappa(κ(w). For anti-NP IgY κ(w) is 0.0119 and for IgM κ(w) is 0.000 indicating 
slight and poor agreement, respectively. We also examined the agreement between WB results 
and RT-PCR results using Cohen’s kappa for binary WB results and weighted kappa for 
graded WB results. In all cases the agreement was slight or poor. For anti-NP IgY WB results 
in relation to UGV-2 RT-PCR Cohen’s κ = -0.195 and κ(w) = -0.074; in relation to S5-like 
PT-PCR Cohen’s κ = 0.024 and κ(w) = 0.008; in relation to SMTV-2 RT-PCR Cohen’s κ = 
0.088 and κ(w) = 0.03. For anti-NP IgM WB results in relation to UGV-2 RT-PCR Cohen’s κ 
= 0.067 and κ(w) = -0.024; in relation to S5-like RT-PCR Cohen’s κ = 0.061 and κ(w) = 0.02; 
in relation to SMTV-2 RT-PCR Cohen’s κ = 0.069 and κ(w) = 0.024. 
Antibody detection by ELISA. Since the quantification of WB results is at best indicative 
of the antibody titres, we decided to set up an ELISA test for the detection of anti-reptarena- 
virus NP antibodies. We used purified UGV-1, recombinant UHV-1 NP, and the C-terminal 
portion of UHV-1 NP (UHV-1 NP-C) as the antigens. 
ELISA results as quantitative variables. We examined the ELISA results against the 
BIBD status and the RT-PCR results using t-test. UGV-1 IgY ELISA OD values were signifi- 
cantly higher for BIBD- (p<0.001) and UGV-2 RT-PCR- (p<0.05) negative animals, whereas 
UGV-1 IgM ELISA OD values were significantly higher for BIBD-positive animals (p<0.05). 
UHV-1 NP IgY ELISA OD values were significantly higher for BIBD- (p<0.001) and UGV-2 
RT-PCR- (p<0.01) negative animals, UHV-1 NP-C IgY ELISA OD values were significantly 
higher for BIBD (p<0.01) and UGV-2 RT-PCR (p<0.01) negative animals, and UHV-1 NP-C 
IgM ELISA OD values were significantly higher for BIBD- (p<0.05) and UGV-2 RT-PCR- 
(p<0.01) negative animals and for SMTV-2 RT-PCR-positive animals (p<0.05). Table 8 pro- 
vides the detailed results of the analysis. 
ELISA results for IgY and IgM from all the tests were analysed against population parame- 
ters and the other tests. At univariate level we used Analysis of Variance (ANOVA) to examine 
associations between age and antibody titres. UGV-1 IgY ELISA titres were the only ones sig- 
nificantly associated with age (F (6,59) = 3.52, p<0.01). Linear regression established that 
weight was significantly associated with ELISA titres for UGV-1 IgY and UGV-1 IgM (Regres- 
sion equations UGV-1 IgY: F(1.67) = 32.4, R2 = 0.326, Predicted UGV-1 IgY = -1.245 + 1.556 
weight; Predicted UGV-1 IgM: F(1.67) = 4.9 = -0.217–0.188 weight). There was no significant 
association between any of the ELISA test results and the animals’ sex. The results of the uni- 
variate analysis are presented in Table 9. 
Using multivariable linear regression, we examined the associations of UGV-1 IgY and IgM 
with BIBD, weight and age. We established that both age and BIBD+ status were significantly 
associated with UGV-1 IgY antibody titres, F(2,63) = 16.94, and they accounted for 32.90% of 
antibody variability (p<0.001). The regression equation is: Predicted UGV- IgY OD(log10) = 
-1.147 + 0.181 age—0.4812 BIBD+. Fig 3A illustrates this association, with BIBD-negative 
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Table 8. ELISA results against RT-PCR and IB detection. 
 
ELISA UGV1 IgY (n) UGV1 IgM GM (n) UHV1 NP IgY (n) UHV1 NP IgM (n) UHV-1 NP-C IgY (n) UHV-1 NP-C IgM (n) 
Alternative test (95%CI) (95%CI) (95%CI) (95%CI) (95%CI) (95%CI) 
BIBD +ve 0.155 (33) 0.561 (33) 0.156 (34) 0.250 (34) 0.251 (34) 0.290 (34) 
 (0.095–0.252) (0.479–0.657) (0.114–0.213) (0.202–0.308) (0.191–0.329) (0.241–0.351) 
BIBD -ve 0.553 (36) 0.448 (36) 0.306 (36) 0.255 (36) 0.556 (36) 0.379 (36) 
 (0.337–0.906) (0.399–0.503) (0.244–0.385) (0.199–0.327) (0.452–0.682) (0.339–0.422) 
t-test t = 3.7246, df = 67 t = -2.3586, df = 67 t = 3.5899, df = 68 t = 0.1294, df = 68 t = 4.771, df = 68 t = 2.5368, df = 68 
 P<0.001 p<0.05 p<0.001 p = 0.903 p<0.001 p<0.05 
UGV-2 RT-PCR +ve 0.209 (42) 0.464 (42) 0.173 (43) 0.254 (43) 0.282 (43) 0.296 (43) 
 (0.133–0.329) (0.398–0.540) (0.132–0.226) (0.214–0.301) (0.221–0.361) (0.254–0.344) 
UGV-2 PR-PCR -ve 0.530 (27) 0.464 (27) 0.326 (27) 0.249 (27) 0.598 (27) 0.402 (27) 
 (0.288–0.975) (0.458–0.596) (0.251–0.123) (0.179–0.346) (0.480–0.744) (0.356–0.454) 
t-test t = 2.5322, df = 67 t = -1.181, df = 67 t = 3.2325, df = 68 t = -0.1199, df = 68 t = 4.2732, df = 68 t = 2.9145, df = 68 
 p<0.05 p = 0.2118 p<0.01 p = 0.9049 p<0.001 p<0.01 
S5-like RT-PCR +ve 0.262 (60) 0.495 (60) 0.207 (61) 0.251 (61) 0.353 (61) 0.333 (61) 
 (0.180–0.382) (0.445–0.551) (0.168–0.256) (0.210–0.301) (0.292–0.427) (0.295–0.375) 
S5-like PT-PCR -ve 0.745 (9) 0.522 (9) 0.339 (9) 0.260 (9) 0.592 (9) 0.335 (9) 
 (0.171–0.324) (0.378–0.718) (0.156–0.733) (0.197–0.344) (0.263–1.330) (0.295–0.375) 
t-test t = 1.9239, df = 67 t = 0.3602, df = 67 t = 1.6353, df = 68 t = 0.1522, df = 68 t = 1.8398, df = 68 t = 0.041, df = 68 
 p = 0.0586 p = 0.7199 p = 0.1068 p = 0.8795 p = 0.0702 p = 0.9674 
SMTV-2 RT-PCR +ve 0.334 (53) 0.506 (53) 0.235 (54) 0.259 (54) 0.407 (54) 0.359 (54) 
 (0.220–0.508) (0.452–0.567) (0.192–0.289) (0.213–0.315) (0.334–0.495) (0.320–0.402) 
SMTV-2 PT-PCR -ve 0.212 (16) 0.475 (16) 0.178 (16) 0.230 (16) 0.292 (16) 0.258 (16) 
 (0.088–0.507) (0.383–0.589) (0.098–0.546) (0.179–0.296) (0.171–0.500) (0.198–0.337) 
t-test t = -1.0373, df = 67 t = -0.5349, df = 67 t = -1.1503, df = 68 t = -0.6136, df = 68 t = -1.4677, df = 68 t = -2.6477, df = 68 
 p = 0.3033 p = 0.5945 p = 0.2541 p = 0.5415 p = 0.1468 p<0.05 
Total 0.301 (69) 0.499 (69) 0.221 (70) 0.252 (70) 0.377 (70) 0.333 (70) 
 (0.207–0.436) (0.452–0.550) (0.180–0.270) (0.215–0.296) (0.312–0.456) (0.299–0.371) 
 
Optical density geometric mean 
https://doi.org/10.1371/journal.pone.0221863.t008 
 
Table 9. Associations between ELISA results and population parameters, univariate analysis. 
 
  
(9 
Sex 
5%CI) 
  Weight 
Linear regression results 
 Age 
ANOVA results 
OD geometric Male Female All p value F Coef Adjusted b ((95% p value F p value 
mean     R
2 
 CI)    
UGV-1 0.208 0.422 0.301 t = -1.9407, (1.67) = -0.245 1.556 p<0.0001 (6,59) = p<0.01 
RT-PCR IgY (0.122– (0.251– (0.207– df = 67 32.4 (-1.532– (1.010–2.102)  3.52  
 0.352) 0.710) 0.436) p = 0.0565 0.316 0.959)     
UGV1 0.540 0.462 0.499 t = 1.6002, (1.67) = -0.217 -0.188 P<0.05 (6.59) = p = 0.2876 
RT-PCR IgM (0.472– (0.400– (0.452– df = 67 4.90 (-0.304 - (-0.357 –-0.185)  1.26  
 0.618) 0.534) 0.550) p = 0.1143 0.0542 -0.131)     
UHV-1 NP 0.242 0.202 0.221 t = 0.8919, (1.68) = -0.673 0.036 p = 0.84 (6,60) = 1 p = 0.4365 
RT-PCR IgY (0.196– (0.142– (0.180– df = 68 0.04 (-0.858– (-0.319–0.391)    
 0.299) 0.287) 0.270) p = 0.3756 -0.141 0.487)     
UHV-1 NP 0.265 0.241 0.252 t = 0.5993, (1,68) = -0.556 -0.092 p = 0.513 (6,60) = p = 0.6398 
RT-PCR IgM (0.228– (0.181– (0.215– df = 68 0.43 (-0.701 - (-0.369–0.186)  0.71  
 0.308) 0.320) 0.296) p = 0.5510 -0.0083 -0.411)     
UHV-1 NPC 0.382 0.373 0.377 t = 1.1234, (1,68) = -0.494 0.153 p = 0.358 (6,60) = p = 0.2093 
RT-PCR IgY (0.298– (0.276– (0.312– df = 68 0.86 (-0.666 (-0.178–0.485)  1.45  
 0.489) 0.504) 0.456) p = 0.9021 -0.0021 –-0.321)     
UHV-1 NP-C 0.335 0.331 0.333 t = 0.1052, (1,68) = -0.514 0.080 p = 0.401 (6,60) = p = 0.598 
RT-PCR IgM (0.294– (0.277– (0 .299– df = 68 0.71 (-0.312 (-0.108–0.268)  0.77  
 0.381) 0.396) 0.371) p = 0.9165 -0.0041 –-0.416)     
https://doi.org/10.1371/journal.pone.0221863.t009 
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Fig 3. Associations of ELISA test results with age and BIBD status. A) UGV1 IgY, B) UGV1 IgM, C) UHV1 NP IgY, D) UHV1 NP IgM, E) UHV1 NPC IgY, F) 
UHV1 NPC IgM. The red lines indicate the ELISA cut-off point. 
 
https://doi.org/10.1371/journal.pone.0221863.g003 
 
animals demonstrating higher antibody titres than BIBD-positive ones. A similar model when 
fitted for UGV-1 IgM did not provide significant results. We include the graphic representa- 
tion (Fig 3B) as the result may indicate an interesting trend of UGV-1 IgM remaining at higher 
levels for BIBD-positive animals because of continuous exposure from circulating virus while 
in BIBD-negative snakes, lack of such exposure may lead to UGV-1 IgM reduction in older 
animals. (Fig 3A–3F) demonstrates the association of all the ELISA test results with age and IB 
detection. 
Multivariable linear regression also established that age, sex and plasma UGV1 IgY were 
significantly associated (p<0.0001) with the weight of the animals, F(3,62) = 38.24 and they 
accounted for 63.22% of weight variability. The regression equation is: Predicted Weight = 
0.079 + 0.075 age + 0.195 sex—0.096 UGV1 IgY OD. Fig 4 demonstrates this association sepa- 
rately for male and female animals. To establish linearity in this and all previous cases, we 
checked the residuals for normalcy using Shapiro-Wilk test and examined a residual versus fit- 
ted values plot. 
We then investigated the potential association between the number of S segments found 
and the antibody response. Of the 23 BIBD-positive snakes in which all three viral S segments 
were detected, six (26.09%) were positive for anti-UGV IgY and 14 (63.64%) for anti-UGV 
IgM antibodies, four (18.18%) carried both IgY and IgM, and seven (31.82%) were negative 
for either antibodies. Among the nine snakes with two S segments were two (22.22%) that 
exhibited anti-UGV IgY antibodies, and three (33.33%) were positive for anti-UGV IgM anti- 
bodies. The two IgY-positive snakes also carried anti-NP IgM antibodies (22.22%); six snakes 
(66.67%) were negative for either antibodies. Both BIBD-positive snakes in which only the 
UGV-/S6-like S segment was detected exhibited an anti-NP IgM response; one also carried 
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Fig 4. Association of body weight and UGV-1 IgY antibodies in female and male snakes. 
https://doi.org/10.1371/journal.pone.0221863.g004 
 
anti-NP IgY antibodies. All seven BIBD-negative animals tested positive for three viral S seg- 
ments carried UGV-specific antibodies, five (71.43%) were IgY-positive, and three (42.86%) 
IgM-positive, one snake (14.29%) was positive for both Igs. Of the animals positive for two S 
segments (n = 23), the majority carried IgY (n = 14; 60.87%), nine (39.13%) were IgM-positive, 
and five (21.74%) were positive for both antibodies; five animals (21.74%) did not exhibit an 
antibody response. Both snakes in which a single viral S segment was detected exhibited both 
an IgY and an IgM response. Of the four RT-PCR negative animals, two (50%) showed a com- 
bined IgY and IgM response, one only had IgY antibodies, and one did not exhibit an anti- 
reptarenavirus response. There is no significant association between the number of segments 
and any of the ELISA results. 
ELISA cut-off points. The background corrected raw ELISA data with cut-off values are 
presented in Fig 5. We tested the BIBD-positive snakes for the presence of anti-UGV-1 IgY 
and IgM antibodies and found nine (26.5%) IgY positives and 19 (57.58%) IgM positives of 
which seven (21.21%) were also IgY-positive. Thirteen animals (39.39%) did not exhibit any 
anti-UGV-1 antibodies (Table 10). Of the 36 BIBD-negative snakes 24 (66.67%) had anti- 
UGV-1 IgY and 16 (44.44%) anti-UGV-1 IgM antibodies, 10 animals (27.78%) showed both 
IgY and IgM; six snakes (16.67%) did not exhibit any anti-UGV-1 antibodies (Table 11). 
Antibodies in BIBD 
PLOS ONE | https://doi.org/10.1371/journal.pone.0221863 September 9, 2019 20 
 
 
 
 
 
 
Fig 5. ELISA results including cut-off values for UGV-1 IgY and IgM, UHV NP IgY and IgM, UHV NP-C IgY and IgM antibodies in BIBD-positive and BIBD- 
negative snakes. 
 
https://doi.org/10.1371/journal.pone.0221863.g005 
 
Within the group of BIBD-positive snakes were six (17.65%) that carried anti-UHV-1-NP 
IgY and seven (20.59%) positive for IgM. Four snakes (11.76%) carried both antibodies and 25 
(73.53%) did not exhibit any anti-UHV-1 antibodies. The examination of UHV-1-NP antibod- 
ies in the BIBD-negative group identified 17 snakes (47.22%) with IgY and nine (25%) with 
IgM antibodies. A combination of IgY and IgM was detected in eight snakes (22.22%), whereas 
18 (50%) were negative for both anti-UHV-1-NP antibodies. Of the BIBD-positives snakes 
seven (20.59%) had anti-UHV-1-NP-C IgY and 10 (29.41%) IgM antibodies. Both antibodies 
were found in five snakes (14.71%) and 22 (64.71%) were negative for IgY and IgM. Among 
the BIBD-negative animals 19 (52.78%) carried IgY and 17 (47.22%) were positive for IgM of 
which 16 (44.44%) also exhibited an IgY antibody response; 16 snakes (44.44%) did not carry 
any anti-UHV-1-NP-C antibodies. 
We examined the agreement of the different ELISA tests with the BIBD status using 
Cohen’s kappa (Table 11). Because significantly more BIBD-positive animals were testing neg- 
ative for IgY (above the cut-off point, see Table 1), and because the measured OD values in 
ELISA were lower in BIBD-positive than in BIBD-negative animals we calculated the test 
agreement, using Cohen’s kappa, considering negative ELISA results equivalent to positive 
BIBD ones. We reversed thus the UGV-1 IgY ELISA results (positive to negative) which led to 
a moderate agreement with BIBD (κ = 0.429). The same applied to UHV-1 NP IgY ELISA (κ = 
0.293) and UHV NP-C IgY (κ = 0.319) which showed fair agreement with BIBD. All IgM 
ELISA results show slight or poor agreement with BIBD (UGV-1 IgM, κ = 0.131; UHV-1 NP 
IgM, κ = -0.045; UHV1 NP-C IgM, κ = -0.179). Results are summarised in Tables 12 and 13 
including the agreement between ELISA results and RT-PCR. All results indicate poor to fair 
agreement between tests. 95% confidence intervals were calculated for Cohen’s kappa and fur- 
ther confirm the lack of agreement between tests [42]. 
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Table 10. Results obtained from the examination of UGV-2, S5-like and TSMV-2 specific S-segments by RT-PCR and UGV-1, UHV-1 NP and UHV-1 NP-C specific 
IgY and IgM antibodies by ELISA—Animals with BIBD. 
RT-PCR UGV-1 UHV-1 NP UHV-1 NP-C 
IgY IgM n = 33 
tested 
IgY and IgM 
n = 33 tested 
IgY IgM IgY and 
IgM 
IgY IgM IgY and 
IgM 
Positive Pos Pos Pos Pos 6/34 Pos 7/34 Pos Pos 7/34 Pos 10/34 Pos 
34/34 (100%) 9/34 (26.47%) 19/33 7/33 (21.21%) (17.65%) (20.59%) 4/34 (20.59%) (29.41%) 5/34 
  (57.58%)    (11.76%)   (14.71%) 
 Neg 25/34 Neg Neg Neg 28/34 Neg 27/34 Neg Neg 27/34 Neg 24/34 Neg 
 (73.53%) 14/33 13/33 (39.39%) (82.35%) (79.41%) 25/34 (79.41%) (70.59%) 22/34 
  (42.42%)    (73.53%)   (64.71%) 
3 Segments 23/34 Pos Pos Pos Pos 2/23 Pos 4/23 Pos Pos 3/23 Pos 7/23 Pos 
(67.65%) 6/23 (26.09%) 14/22 4/22 (18.18%) (8.7%) (17.39%) 1/23 (13.04%) (30.43%) 2/23 
  (63.64%)    (4.35%)   (8.7%) 
 Neg 17/23 Neg Neg Neg 21/23 Neg 19/23 Neg Neg 20/23 Neg 16/23 Neg 
 (73.91%) 8/22 7/22 (31.82%) (91.3%) (82.61%) 18/23 (86.96%) (69.57%) 15/23 
  (36.36%)    (78.26%)   (65.22%) 
2 Segments Pos Pos Pos Pos 3/9 Pos 2/9 Pos Pos 3/9 Pos 2/9 Pos 
9/34 (26.47%) 2/9 (22.22%) 3/9 2/9 (33.33%) (22.22%) 2/9 (33.33%) (22.22%) 2/9 
  (33.33%) (22.22%)   (22.22%)   (22.22%) 
 Neg Neg Neg Neg 6/9 Neg 7/9 Neg Neg 6/9 Neg 7/9 Neg 
 7/9 (77.78%) 6/9 6/9 (66.67%) (77.78%) 6/9 (66.67%) (77.78%) 6/9 
  (66.67%) (66.67%)   (66.67%)   (66.67%) 
1 Segment Pos Pos Pos Pos Pos Pos Pos Pos Pos 
2/34 (5.88%) 1/2 2/2 1/2 1/2 1/2 1/2 1/2 1/2 1/2 
 (50%) (100%) (50%) (50%) (50%) (50%) (50%) (50%) (50%) 
 Neg Neg Neg Neg Neg Neg Neg Neg Neg 
 1/2 0/2 0/2 1/2 1/2 1/2 1/2 1/2 1/2 
 (50%) (0%) (0%) (50%) (50%) (50%) (50%) (50%) (50%) 
 
Pos–positive; Neg—negative 
https://doi.org/10.1371/journal.pone.0221863.t010 
 
 
Using univariate analysis, we examined the ELISA test results based on the cut-off points 
for associations with population parameters. There is no significant association between ani- 
mal sex and any of the ELISA results. The presence of UGV-IgY is significantly associated with 
weight. The geometric mean (GM) weight of UGV-IgY-positive animals (n = 34) is 3.809 kg 
(95% CI: 3.159–4.594) while for UGV-IgY-negative animals (n = 36) the geometric mean 
weight is 2.193 kg (95%CI: 1.858–2.589kg, p<0.0001). This association remained significant 
after stratification for sex for both male and female animals (Male: UGV-IgY positive animals 
(n = 14) GM = 2.448 kg [95%CI: 1.995–3.004], UGV-IgY negative animals (n = 20) GM = 
1.809 kg [95%CI: 1.484–2.206], p<0.05; Female: UGV-IgY positive animals (n = 16) GM = 
5.192 kg [95%CI: 4.283–6.293 ], UGV-IgY negative animals (n = 20) GM = 2.788 kg [95%CI: 
2.167–3.588], p<0.001). A significant association was also identified between UGV-IgY and 
the animals’ age. UGV-IgY-positive animals are significantly older than negative animals 
(p<0.001). The average age is 5.313 years (95%CI: 4.783–5.842) and 4 years (95%CI: 3.567– 
4.329) for UGV-IgY positive animals (n = 32) and negative animals (n = 35) respectively. After 
stratifying for sex, the association remained significant for female animals (UGV1 IgY positive 
animals (n = 20) mean age = 5.5 years) [95%CI: 4.865–6.135]; UGV-IgY negative (n = 16) 
mean age = 4.063 years [95%CI: 3.568–4.557], p<0.005). No other association was identified 
between any of the ELISA results based on the cut-off point and population parameters. All 
the results are presented in Tables 14 and 15. 
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Table 11. Results obtained from the examination of UGV-2, S5-like and TSMV-2 specific S-segments by RT-PCR and UGV-1, UHV-1 NP and UHV-1 NP-C specific 
IgY and IgM antibodies by ELISA—Animals without BIBD. 
RT-PCR UGV-1 UHV-1 NP UHV-1 NP-C 
IgY IgM IgY and IgM IgY IgM IgY and IgM IgY IgM IgY and IgM 
Positive/ 
Negative 36/36 
(100%) 
Pos 24/36 
(66.67%) 
Pos 
16/36 
(44.44%) 
Pos 
10/36 
(27.78%) 
Pos 17/36 
(47.22%) 
Pos 9/36 (25%) Pos 
8/36 
(22.22%) 
Pos 19/36 
(52.78%) 
Pos 17/36 
(47.22%) 
Pos 
16/36 
(44.44%) 
Neg 12/36 
(33.33%) 
Neg 
20/36 
(55.56%) 
Neg 
6/36 
(16.67%) 
Neg 19/36 
(52.78%) 
Neg 27/36 
(75%) 
Neg 
18/36 
(50%) 
Neg 17/36 
(47.22%) 
Neg 19/36 
(52.78%) 
Neg 
16/36 
(44.44%) 
Positive 32/36 
(88.89%) 
Pos 
21/32 (65.63%) 
Pos 
14/32 
(43.75%) 
Pos 
8/32 
(25.00%) 
Pos 
16/32 (50%) 
Pos 
9/32 (28.13%) 
Pos 
8/32 
(25.00%) 
Pos 
17/32 (53.13%) 
Pos 
16/32 (50%) 
Pos 
15/32 
(46.88%) 
Neg 
11/32 (34.38%) 
Neg 
18/32 
(56.25%) 
Neg 
5/32 
(15.63%) 
Neg 
16/32 (50%) 
Neg 23/32 
(71.88%) 
Neg 
15/32 
(46.88%) 
Neg 
15/32 (46.88%) 
Neg 
16/32 (50%) 
Neg 
14/32 
(43.75%) 
3 Segments 7/32 
(21.88%) 
Pos 
5/7 (71.43%) 
Pos 
3/7 
(42.86%) 
Pos 
1/7 
(14.29%) 
Pos 
4/7 (57.14%) 
Pos 
2/7 (28.57%) 
Pos 
1/7 
(14.29%) 
Pos 
3/7 (42.86%) 
Pos 
3/7 (42.86%) 
Pos 
3/7 
(42.86%) 
Neg 
2/7 
(28.57%) 
Neg 
4/7 
(57.14%) 
Neg 
0/7 
(0%) 
Neg 
3/7 (42.86%) 
Neg 
5/7 (71.43%) 
Neg 
2/7 
(28.57%) 
Neg 
4/7 (57.14%) 
Neg 
4/7 (57.14%) 
Neg 
4/7 
(57.14%) 
2 Segments 23/32 
(71.88%) 
Pos 
14/23 (60.87%) 
Pos 
9/23 
(39.13%) 
Pos 
5/23 
(21.74%) 
Pos 
11/23 (47.83%) 
Pos 
6/23 (26.09%) 
Pos 
6/23 
(26.09%) 
Pos 
13/23 (56.52%) 
Pos 12/23 
(52.17%) 
Pos 
11/23 
(47.83%) 
Neg 
9/23 (39.13%) 
Neg 
14/23 
(60.87%) 
Neg 
5/23 
(21.74%) 
Neg 12/23 
(52.17%) 
Neg 17/23 
(73.91%) 
Neg 
12/23 
(52.17%) 
Neg 10/23 
(43.48%) 
Neg 
11/23 (47.83%) 
Neg 
9/23 
(39.13%) 
1 Segment 2/32 
(6.25%) 
Pos 
2/2 
(100%) 
Pos 
2/2 
(100%) 
Pos 
2/2 
(100%) 
Pos 
1/2 
(50%) 
Pos 
1/2 
(50%) 
Pos 
1/2 
(50%) 
Pos 
1/2 
(50%) 
Pos 
1/2 
(50%) 
Pos 
1/2 
(50%) 
Neg 
0/2 
(0%) 
Neg 
0/2 
(0%) 
Neg 
0/2 
(0%) 
Neg 
1/2 
(50%) 
Neg 
1/2 
(50%) 
Neg 
1/2 
(50%) 
Neg 
1/2 
(50%) 
Neg 
1/2 
(50%) 
Neg 
1/2 
(50%) 
Negative 4/36 
(11.11%) 
Pos 
3/4 
(75%) 
Pos 
2/4 
(50%) 
Pos 
2/4 
(50%) 
Pos 
1/4 
(25%) 
Pos 
0/4 
(0%) 
Pos 
0/4 
(0%) 
Pos 
2/4 
(50%) 
Pos 
1/4 
(25%) 
Pos 
1/4 
(25%) 
Neg 
1/4 
(25%) 
Neg 
2/4 
(50%) 
Neg 
1/4 
(25%) 
Neg 
3/4 
(75%) 
Neg 
4/4 (100%) 
Neg 
3/4 
(75%) 
Neg 
2/4 
(50%) 
Neg 
3/4 
(75%) 
Neg 
2/4 
(50%) 
 
Pos–positive; Neg—negative 
https://doi.org/10.1371/journal.pone.0221863.t011 
 
Discussion 
In this study, we investigated the association between BIBD, pathogen detection, population 
parameters and serological findings in a cohort of snakes from one breeding colony. As our 
previous studies had implied an association between BIBD and low antibody levels [7,14], the 
main focus of this study was on a potential link between anti-reptarenavirus antibody levels 
and BIBD. We hypothesised that some reptarenavirus S segments can be found more fre- 
quently in snakes with BIBD, and that healthy and diseased snakes would show different S seg- 
ment profiles. We examined a panel of 70 blood samples, evenly distributed by sex, collected 
on the same day from the entire animal cohort. Because snakes are poikilotherms, we consid- 
ered minimising the environmental influence on the immune response to be essential. There- 
fore, the study was restricted to a single breeding colony where animals are kept under 
virtually the same husbandry conditions with regards to moisture, light, feeding regime and 
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-ve    
Total 
10 
34 
17 
36 
27 
70 
 
 
Table 12. ELISA results based on the cut-off points against inclusion detection including test agreement and sensitivity/Specificity. 
 
ELISA test  
+ve 
BIBD 
-ve 
 
Total 
Cohen’s κ 
(95%CI) 
Sensitivity Specificity 
UGV1 IgY +ve 25 11 34 κ = 0.429 73.53% 69.44% 
-ve 9 25 36 (0.213–0.645) (63.19–83.86) % (58.65–80.24) 
UGV1 IgM +ve 14 20 34 κ = -0.131 42.42% 44.44% 
-ve 19 16 35 (-0.360–0.097) (30.76–54.09) % (32.72–56.17) 
UHV1 NP IgY +ve 28 19 47 κ = 0.293 82.35% 47.22% 
-ve 6 17 23 (0.075–0.510) (73.42–91.28) % (35.53–58.92) 
UHV1 NP IgM +ve 7 9 16 κ = 0.043 79.41% 25.00% 
-ve 24 27 54 (-0.145–0.232) (69.94–88.88) % (14.86–35.14) 
UHV1 NP-C IgY +ve 27 17 44 κ = 0.319 79.41% 52.78% 
-ve 7 19 26 (0.100–0.539) (69.94–88.88) % (41.08–64.47) 
UHV1 NP-C IgM +ve 24 19 43 κ = 0.177 70.59% 47.22% 
 
 
 
missing value 
https://doi.org/10.1371/journal.pone.0221863.t012 
 
temperature, except that male snakes are kept at 2–5˚C lower temperatures than females to 
increase reproductive activity. 
We started by dividing the sample panel in BIBD positives and negatives based on the 
detection of IBs in blood cells, using blood smears stained under quality controlled conditions. 
We used the presence of IBs in combination with confirmed reptarenavirus infection as the 
diagnostic criteria for BIBD, since we consider it likely that the presence of reptarenavirus NP 
in the form of IBs in cells will eventually result in clinical signs and death of affected animals 
[1,12,13]. The examination of population parameters in our study did not show an association 
of age and the presence of IB, suggesting that the time and duration of the infection would not 
 
 
Table 13. Agreements of ELISA tests with IB detection and RT-PCR. 
 
ELISA test BIBD   UGV-2 S5-like  SMTV-2  
 +ve -ve Cohen’s κ +ve -ve Cohen’s κ +ve 
(95%CI) 
-ve Cohen’s κ +ve -ve Cohen’s κ Total 
UGV1 IgY +ve 25 11 κ = 0.429 28 8 0.339 34 2 0.153 26 10 -0.103 36 
-ve 9 25 (0.213–0.645) 15 19 (0.119–0.558) 27 7 (-0.009–0.316) 28 6 (-0.307–0.102) 34 
UGV1 IgM +ve 14 20 κ = -0.131 21 13 0.018 30 4 0.025 25 9 -0.064 34 
-ve 19 16 (-0.360–0.097) 21 14 (-0.209–0.244) 30 5 (-0.134–0.184) 28 7 (-0.267–0.139) 35 
UHV1 NP IgY +ve 28 19 κ = 0.293 33 14 0.256 42 5 0.080 35 12 -0.088 47 
-ve 6 17 (0.075–0.510) 10 13 (0.018–0.494) 19 4 (-0.129–00289) 19 4 (-0.307–0.131) 23 
UHV1 NP IgM +ve 27 27 κ = 0.043 35 19 0.119 47 7 -0.005 40 14 -0.134 54 
-ve 7 9 (-0.145–0.232) 8 8 (-0.103–0.342) 14 2 (-0.220–0.209) 14 2 (-0.333–0.064) 16 
UHV1 NP-C IgY +ve 27 17 κ = 0.319 33 11 0.363 40 4 0.117 33 11 -0.063 44 
-ve 7 19 (0.100–0.539) 10 16 (0.133–0.592) 21 5 (-0.083–0.318) 21 5 (-0.284–0.159) 26 
UHV1 NP-C IgM +ve 24 19 κ = 0.177 31 12 0.276 37 6 -0.032 30 13 -0.207 43 
-ve 10 17 (-0.051–0.405) 12 15 (0.037–0.515) 24 3 (-0.209–0.144) 24 3 (-0.400 –-0.014) 27 
Total 34 36 43 27 61 9 54 16 70 
missing value 
        
https://doi.org/10.1371/journal.pone.0221863.t013 
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Table 14. IgY ELISA cut-off point results against population parameters, univariate analysis including stratification by sex. 
 
 Sex 
(Row%) 
(Col%) 
Weight 
(95% CI) 
N = 70 
Age(n) 
(95% CI) 
N = 67 
 
 M F Total M F Total M F Total 
UGV- 1 20 16 36 1.809 2.788 2.193 3.947 (19) 4.063 (16) 4.000 (35) 
IgY ELISA (55.56%) (44.44%) (100.00%) (1.484–2.206) (2.167–3.588) (1.858–2.589) (3.220–4.674) (3.568–4.557) (3.567–4.329) 
-ve (58.82%) (44.44%) (51.43%)       
UGV-1 14 20 34 2.448 5.192 3.809 5.000 (12) 5.500 (20) 5.313 (32) 
IgY ELISA (41.18%) (58.82%) (100.00%) (1.995–3.004) (4.283–6.293) (3.159–4.594) (3.951–6.049) (4.865–6.135) (4.783–5.842) 
+ve (41.18%) (55.86%) (48.57%)       
χ2 = 1.4473, p = 0.229 t = -2.1855, t = -4.2166, t = -4.480, t = -1.8251, t = -3.609, df = 34 t = -3.935, 
 df = 32 
p<0.05 
df = 34 
p<0.001 
df = 68 
p<0.0001 
df = 29 
p = 0.0783 
p<0.005 df = 65 
p<0.001 
UHV-1 NP 23 24 47 2.005 3.711 2.745 4.500 (22) 4.750 (24) 4.630 (46) 
IgY ELISA (48.94%) (51.06%) (100.00%) (1.666–2.412) (2.930–4.701) (2.313–3.259) (3.819–5.181) (4.163–5.337) (3.865–5.373) 
-ve (67.65%) (66.67%) (67.14%)       
UHV-1 NP 11 12 23 2.145 4.436 3.134 4.000 (9) 5.083 (12) 4.619 (21) 
IgY ELISA (47.83%) (52.17%) (100.00%) (1.622–2.837) (3.268–6.020) (2.442–4.020) (2.562–5.438) (4.207–5.959) (3.865–5.374) 
+ve (32.35%) (33.33%) (32.86%)       
χ2 = 0.076, p = 0.930 t = -0.4349, t = -0.9422, t = -0.894, t = 0.773, df = 29 t = -0.6797, t = 0.285, 
 df = 32 
p = 0.6667 
df = 34 
p = 0.3527 
df = 68 
p = 0.3746 
p = 0.4458 df = 34 
p = 0.5013 
df = 65 
p = 9774 
UHV-1 21 23 44 2.121 3.861 2.901 4.526 (19) 4.739 (23) 4.643 (42) 
NP-C (47.73%) (52.27%) (100.00%) (1.745–2.576) (3.086–4.831) (2.446–3.440) (3.784–5.269) (4.265–5.213) (4.237–5.049) 
IgY ELISA 
-ve 
(61.76%) (63.89%) (62.86%)       
UHV-1 13 13 26 1.938 4.079 2.812 4.083 (12) 5.077 (13) 4.600 (25) 
NP-C (50.00%) (50.00%) (100.00%) (1.508–2.492) (2.870–5.798) (2.186–3.618) (2.951–5.215) (3.989–6.165) (3.846–5.354) 
IgY ELISA 
+ve 
(38.24%) (36.11%) (37.14%)       
χ2 = 0.0338, p = 0.854 t = 0.6009, t = -0.2922, t = 0.2146, t = 0.7342, t = -0.7021, t = 0.112, 
 df = 32 df = 34 df = 68 df = 29 df = 34 df = 35 
 p = 0.5521 p = 0.7718 p = 0.831 p = 0.4687 p = 0.4874 p = 0.914 
Total 34 36 70 2.049 3.938 2.867 4.355 (31) 4.861 (36) 4.626 (67) 
 (48.57%) (51.43%) (100.00%) (1.770–2.372) (3.287–4.719) (2.497–3.293) (3.759–4.950) (4.395–5.327) (4.260–4.994) 
 (100.00%) (100.00%) (100.00%)       
 
Kg, geometric mean 
Mean Years 
https://doi.org/10.1371/journal.pone.0221863.t014 
 
be a factor in the development of BIBD, though this is highly speculative as data on, for exam- 
ple, the introduction of individual animals was not available. Also, a dependency of sex and 
BIBD could not be shown, but we could demonstrate a statistically significant association 
between BIBD and reduced body weight in female snakes. While this may reflect the low num- 
ber of snakes included in the study, it might also be indicative of metabolic or behavioural 
changes in the infected snakes. Since reptarenavirus replication is temperature sensitive [43], 
one could also speculate that the viruses replicate more efficiently in female snakes as these are 
housed at slightly higher temperatures. Further studies on the optimal reptarenavirus replica- 
tion temperature would be required to address this hypothesis. 
By NGS and de novo genome assembly, we identified two pairs of hartmanivirus L and S 
segments, several reptarenavirus L segments but only a single reptarenavirus S segment 
(UGV-like) from the RNA of a BIBD-positive blood pool [10]. Interestingly, reads matching 
reptarenaviruses were clearly less abundant in the RNA sample extracted from the BIBD-nega- 
tive blood. This finding could indicate higher replication or more intense viraemia in the 
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Table 15. IgM ELISA cut-off point results against population parameters, univariate analysis including stratification by sex. 
 
 Sex 
(Row%) 
(Col%) 
Weight
(95% CI) 
UGV-1: N = 69; UHV- NP, UHV-1 NP-C: N = 70 
Age(n) 
(95% CI) 
UGV-1: N = 66; UHV-1 NP, UHV-1 NP-C: N = 67 
 
 M F Total M F Total M F Total 
UGV- 1 14 20 34 2.623 3.771 3.248 5.000 (13) 4.750 (20) 4.848 (33) 
IgM ELISA (41.18%) (58.82%) (100.00%) (2.204–3.120) (2.867–4.962) (2.712–3.889) (3.983–6.017) (4.145–5.355) (4.338–5.359) 
-ve (41.18%) (57.14%) (49.28%)       
UGV-1 20 15 35 1.724 3.949 2.459 3.889 (18) 4.867 (15) 4.333 (33) 
IgM ELISA (57.14%) (42.86%) (100.00%) (1.424–2.087) (3.089–5.048) (2.008–3.011) (3.167–4.610) (4.060–5.674) 3.797–4.870) 
+ve (58.82%) (42.86%) (50.72%)       
Total 34 35 69 2.049 3.938 2.820 4.355 (31) 4.800 (35) 4.595 (66) 
 (49.28%) (50.72%) (100.00%) (1.770–2.372) (3.287–4.719) (2.461–3.233) (3.759–4.950) (4.338–5.262) (4.225–5.957) 
 100.00%) (100.00%) (100.00%)       
χ2 = 1.7590, p = 0.185 t = 3.2678, t = -0.2540, t = 2.0827, t = 1.968, df = 29 t = -0.2502, t = 1.417, 
 df = 32 
p<0.01 
df = 33 
p = 0.818 
df = 67 
p<0.05 
p = 0.0578 df = 33 
p = 0.8040 
df = 67 
p = 0.161 
UHV-1 NP 27 27 54 2.042 3.841 2.801 4.280 (25) 4.778 (27) 4.538 (52) 
IgM ELISA (50.00%) (50.00%) (100.00%) (1.757–2.374) (3.109–4.746) (2.404–3.263) (3.633–4.927) (4.237–5.319) (4.128–4.949) 
-ve (79.41%) (75.00%) (77.14%)       
UHV-1 NP 7 9 16 2.075 4.245 3.104 4.667 (6) 5.111 (9) 4.629 (15) 
IgM ELISA (43.75%) (56.25%) (100.00%) (1.212–3.553) (2.764–6.521) (2.183–4.413) (2.603–6.730) (3.994–6.228) (4.034 
+ve (20.59%) (25.00%) (22.86%)      (4.260–4.994) 
χ2 = 0.1930, p = 0.660 t = -0.0881, t = -0.4807, t = -0.6185, t = -0.5174, t = -0.6237, t = -0.893, 
 df = 32 df = 34 df = 68 df = 29 df = 34 df = 65 
 p = 0.9304 p = 0.6338 p = 0.538 p = 0.6088 p = 0.5370 p = 0.375 
UHV-1 21 22 43 2.155 3.754 2.863 4.350 (20) 4.682 (22) 4.524 (42) 
NP-C (48.84%) (51.16%) (100.00%) (1.812–2.564) (3.003–4.602) (2.436–3.364) (3.617–5.083) (4.200–5.163) (4.109–4.938) 
IgM ELISA 
-ve 
(61.76%) (61.11%) (61.43%)       
UHV-1 13 14 27 1.888 4.247 2.875 4.364 (11) 5.143 (14) 4.800 (25) 
NP-C (48.15%) (51.85%) (100.00%) (1.414–2.521) (3.018–5.978) (2.204–3.750) (3.152–5.576) (4.134–6.152) (4.065–4.994) 
IgM ELISA 
+ve 
(38.24%) (38.89%) (38.57%)       
χ2 = 0.0032, p = 0.955 t = 0.8911, t = -0.6709, t = -0.295, df = 68 t = -0.022, df = 29 t = -0.9792, t = -0.723, 
 df = 32 
p = 0.3795 
df = 34 
p = 0.5068 
p = 0.797 p = 0.9826 df = 34 
p = 0.3344 
df = 65 
p = 0.472 
Total 34 36 70 2.049 3.938 2.867 4.355 (31) 4.861 (36) 4.626 (67) 
 (48.57%) (51.43%) (100.00%) (1.770–2.372) (3.287–4.719) (2.497–3.293) (3.759–4.950) (4.395–5.327) (4.260–4.994) 
 (100.00%) (100.00%) (100.00%)       
 
Kg, geometric mean 
Mean Years 
https://doi.org/10.1371/journal.pone.0221863.t015 
 
BIBD-positive snakes, however, it could also be explained by unknown factors related to NGS 
library preparation. As we aimed to study the immune response using NP as the antigen, we 
used the S segment primers of our previous study [1] in RT-PCRs to screen the pools, and 
identified two additional S segments (S5-like and TSMV-2) within the pools. Screening of all 
individual samples for UGV-like, S5-like, and TSMV-2 S segments by RT-PCR showed that 
97.1% of the BIBD-positive snakes carried the UGV-like S-segment. This observation is well in 
line with previous studies, in which we [1,11] and others [12] have observed that UGV-/ 
S6-like S segments are often found in snakes with BIBD. In contrast, we found the UGV-/ 
S6-like S segment only in 27.8% of the BIBD-negative snakes. As the mechanisms behind IB 
formation are still unknown, one could speculate that UGV-/S6-like NP would be more prone 
to IB formation. However, in our first report on reptarenaviruses in snakes, we purified IBs 
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from infected cell cultures and used peptide mass fingerprinting to identify the main protein 
component as University of Helsinki virus-1 (UHV-1) NP. This finding suggests that IB for- 
mation is similar between different reptarenavirus species (or S segments). Thus one explana- 
tion on why UGV-/S6-like S segments are often found in snakes with BIBD could instead lie in 
the GPC that is also carried in the S segment. The origin and reservoir host(s) of reptarena- 
viruses remain unknown, however, it seems obvious that UGV-/S6-like GPC allows the virus 
to spread efficiently among boas. As IBs are found in various tissues, the UGV-/S6-like GPC 
could also allow wide tissue tropism. Our findings indicated that detection of UGV-/S6-like S 
segment had the closest substantial agreement (κ = 0.6878) with BIBD. However, further work 
will be required to establish the sensitivity and specificity of UGV-/S6-like S segment detection 
in BIBD diagnosis. 
The reptile immune response is not known in great detail, and its description is often sub- 
jected to a comparison with the mammalian immune system. It is also unclear how much 
immune response mechanisms vary within the class Reptilia or even within the clade Ophidia 
inside the order Squamata since studies on the immune response of snakes partially report 
controversial findings, for instance regarding the increase in titres after repeated antigen expo- 
sure in colubrid snakes [40]. Also, different IgY isotypes of certain snake species have been 
described [37], and a secretory immunoglobulin has only been found in the bile of the north- 
western garter snake (Thamnophis ordinoides) [44]. The fact that we studied samples collected 
at a single time point from naturally infected snakes for which the time of infection was 
unknown, made the evaluation of antibody response kinetics impossible. However, the analy- 
sis of IgY and IgM antibodies by WB and ELISA showed that the presence of anti-UGV NP 
IgY is negatively correlated to the presence of IB and thereby BIBD (Fig 2). Although GPC and 
NP are encoded by the S segment, it remains to be studied whether GPC induces a similar 
immune response. We could not detect anti-GPC antibodies by WB, however, the result most 
likely reflects lack of sensitivity rather than lack of antibodies since we used purified virions 
(the NP is by far the most prominent protein in the virion) as the antigen. Further evidence of 
a possible association between infection with a virus bearing UGV-/S6-like S segment and 
BIBD is the observation that we found a significant positive association between weight and 
plasma UGV1 IgY titres. The observed variable occurrence of IgY and IgM antibodies in indi- 
vidual snakes could be due to the prolonged persistence of IgM and the variable onset of IgY 
production [21,39]. Anti-UGV NP IgM antibody titres showed a trend to lower in the older 
BIBD-negative snakes, which could reflect exhaustion of the immune system or a gradual class 
switch towards IgY. The current knowledge on the role of IgM and its age dependency in pro- 
tective immunity in snakes is scarce. Natural antibodies (NAbs) are thought to compensate the 
decreasing sensitivity of the adaptive immune system in ageing snakes [45]. Interestingly, 
NAbs are also suggested to provide protection against mammarenavirus (LCMV) infection by 
epitope recognition [46]. 
The timing of infection greatly influences the immune response, as shown for LCMV, the 
prototypic arenavirus. Exposure in utero or as a neonate results in chronic infections [1,47]. 
Persistently infected LCMV carriers were thought to develop a state of tolerance, accepting the 
virus as endogenous, and therefore do not respond by antibody production [48]. However, 
later studies demonstrated an immunological response towards LCMV and concluded that 
low antibody levels were due to the formation of immune complexes that were deposited in 
the glomeruli of the kidney [49]. Further studies are needed to demonstrate whether such 
immune complexes are present in snakes with BIBD and/or in snakes infected with reptarena- 
viruses in utero or as neonates. Several studies also elucidated a dependency of antibody pro- 
duction on different strains of viruses and mice and a different IgG isotype profile in chronic 
vs. acute murine infections [50]. These antibody profiles were attributed to involvement of 
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different T cell populations in acute and chronic infections, and associated with varying clini- 
cal signs [50]. Extensive studies by Oldstone and colleagues with the LCMV Armstrong 53b 
strain (ARM) as the parental virus demonstrated the emergence of virus variants with varying 
tissue tropism in mice [51]. Infection with the parental ARM isolate induced a strong CD8+ T 
cell response, while the CD8+ T cell response was aborted in mice infected with clone 13 (Cl 
13) isolated from lymphoid cells of neonate mice infected with ARM [51]. LCMV strains and 
variants with high affinity for α-dystroglycan (e.g. Cl 13), the cellular receptor for Old World 
mammarenaviruses [52], can enter dendritic cells (DCs) [51]. Infected DCs can then be 
destroyed by the antiviral CD8+ T cell response [53] or remain functionally impaired [51]. The 
loss of the DC function as professional antigen presenting cells significantly contributes to the 
overall immunosuppression seen as a consequence of LCMV infection [51]. The receptor and 
the ability of reptarenaviruses to infect DCs are currently unknown. However, like LCMV 
[54], reptarenaviruses infect lymphoid cells [55], and could thus use immunosuppression 
mechanisms similar to those employed by LCMV. One could also speculate that the swarm of 
S segments often found in snakes with BIBD would contribute to immunosuppression by 
enabling a broader cell tropism for the virus. 
Another aspect of LCMV induced immunosuppression is the exhaustion of CD4+ and 
CD8+ T cells that occurs in chronically LCMV infected mice [56,57]. Furthermore, the func- 
tional impairment of CD4+ T cells negatively influences the antibody response [56,57]. Also, 
the exhaustion of CD4+ T cells reduces the production of antibodies, as demonstrated by pro- 
viding virus-specific CD4+ T cells from transgenic mice to chronically infected animals [56]. 
Mice persistently infected with LCMV do not possess LCMV-specific CD8+ T cells [50], and 
CD4+ T cells are absent in transplacentally infected mice [57]. The attenuation of T cell depen- 
dent immune functions as well as immune complex formation support the assumption that 
animals infected via vertical transmission show lower antibody levels than horizontally 
infected animals. It is possible that vertical transmission also occurs for maternal antibodies in 
ovoviviparous snakes, such as B. constrictor. This could theoretically compensate for the 
embryo’s immunological incompetence; however, how this aligns with the fact that persis- 
tently infected mothers pass both their reptarena- [1] and hartmaniviruses [10] to the newborn 
is not clear. Many snakes examined in the present study are related, as they represent a breed- 
ing colony; therefore, it is not possible to determine how many were horizontally infected. It is 
tempting to speculate that the snakes with high antibody titres were horizontally infected, 
whereas the BIBD-positive animals with low antibody titres were vertically infected. This 
would tie in with observations on LCMV which leads to reduced levels of IgG2a subclass in 
persistently infected mice [50]. LCMV Cl 13 can induce persistent infection, which results in 
exhaustion of virus-specific T cells and is associated with generalized immunosuppression in 
adult mice [51]. Something similar could occur during reptarenavirus infection. It is possible 
that there are reptarenavirus S segments with point mutations, similar to that in LCMV Cl 13 
that alter the cell tropism and contribute to immunosuppression. Alternatively, multiple S seg- 
ments could allow infection of different subsets of lymphoid cells, thus resulting in immuno- 
suppression similar to that of LCMV Cl 13. In addition to the antibody and T cell responses, 
reptarenaviruses can be expected to influence the innate immune system in a manner similar 
to that of mammarenaviruses, i.e. via inhibition of type I interferon production [10,17,18,58]. 
Indeed, a general reptarenavirus-induced immunosuppression would tie in with the increased 
incidence of bacterial infections and/or neoplastic processes in snakes with BIBD [2–4]. 
This is to our knowledge the first report to thoroughly assess the adaptive immune response 
of boid snakes towards reptarenaviruses. By characterising a single breeding collection, we 
could demonstrate that one individual virus, UGV-/S6-like S segment, was strongly associated 
with BIBD. Supporting the link between the presence of UGV-/S6-like S segment and BIBD, 
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we found a negative correlation between BIBD and the presence of anti-UGV NP antibodies. 
Future studies, either longitudinal or experimental infection driven, are needed to understand 
the kinetics of the antibody response in snakes with reptarenavirus infection. Our results do, 
however, suggest that presence/absence of UGV-/S6-like S segment RNA and presence/ 
absence of anti-UGV NP IgY antibodies could serve to a limited extent in the ante mortem 
diagnostics of BIBD. 
 
Materials and methods 
Study cohort and samples, cytological examination 
We studied a breeding collection of 70 Boa constrictor snakes comprising 36 female and 34 
male adult individuals, aged between two and eight years (Table 1). Husbandry conditions 
included humidity of approximately 60% and a season-dependent light regime with photoperi- 
ods of 12–13 hours during warm and 9–10 hours during cold months. Female snakes were 
kept at an environmental temperature of 26–33˚C with a drop of 3–4˚C during night, but not 
deceeding 24˚C whereas the males were kept at an environmental temperature approximately 
2–5˚C lower than the females with a minimum temperature of 23˚C The cohort included two 
debilitated snakes (one male, animal 1.20; one female, animal 1.29) and one female snake with 
cloacal prolapse (animal 1.18); the remaining animals were clinically healthy. In June 2015, 
one snake from the collection had been euthanised due to clinical signs, and post mortem 
examination had confirmed BIBD diagnosis. Subsequent analysis of blood samples from 14 
snakes had revealed the presence of cytoplasmic IBs in blood cells of eight snakes, confirmed 
that they also suffered from BIBD. These findings prompted the owner to have the entire 
breeding colony tested for BIBD a year later. In July 2016, blood samples were collected in 1.3 
ml K3E EDTA tubes (Sarstedt) by either caudal tail vein venipuncture or cardiocentesis. All 
snakes were weighed before bleeding. No ethical permissions were required for these diagno- 
sis-motivated blood samplings. 
 
Blood samples and smears 
Cytological examination of blood smears, which presents the current standard ante mortem 
diagnostic tool [3,59], served to confirm BIBD diagnosis. We prepared two blood smears for 
each animal, stained with May-Gru¨nwald-Giemsa, and used light microscopy for IB detection 
in blood cells as described [1]. From the remaining blood, ca. 1 ml each, we separated plasma 
by centrifugation at 1,200 x g for 2 min, and stored the cell-enriched blood and plasma at 
-80˚C. 
 
Next generation sequencing (NGS) 
NGS served to identify the “reptarenavirome” of the breeding collection, and to allow the set- 
ting up of virus-specific RT-PCRs for screening of the entire collection. For NGS, we prepared 
two pooled samples of cell-enriched blood: 1. three snakes without evidence of BIBD (no IBs 
in blood cells), 2. three snakes with confirmed BIBD (abundant IBs in blood cells), and per- 
formed RNA extraction, NGS library preparation, and genome assembly as described [1,60]. 
 
Reverse transcriptase-polymerase chain reaction (RT-PCR) 
We were interested in sequencing the S segments present in the breeding colony, since the S 
segment bears the NP which we used as the antigen in the antibody assays. As we only recov- 
ered a single complete reptarenavirus S segment (University of Giessen virus-1, UGV-1, Gen- 
Bank accession MH483061) by NGS and de novo assembly [10], we decided to use the virus- 
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specific primers of our previous study [1] to screen three additional RNA pools prepared from 
blood samples by RT-PCR: one BIBD-negative (no evidence of IB in blood cells) and two 
BIBD-positive. By this approach, we detected: University of Giessen virus-like (UGV-2 and 
UGV-3, primers [1]), S5-like (S5-like, primers [1]), and Tavallinen suomalainen mies virus-2 
(TSMV-2, primers [1]) S segments in the BIBD-positive RNA pools; and S5-like and TSMV-2 
S segments in the BIBD-negative RNA pool. We then used these three primer pairs to screen 
blood samples of the entire collection by RT-PCR. Additionally, we screened the collection by 
RT-PCR with primers targeting the L segments of two hartmaniviruses identified by NGS and 
de novo assembly in the BIBD positive pool, i.e. Old Schoolhouse viruses 1 and 2 (OScV-1, 
OScV-2) described in a previous study [10]. 
We did RNA extractions from cell-enriched EDTA blood (100 μl) as described [1], but 
introduced a mechanical homogenization step using a Retsch MM300 TissueLyser (QIAGEN) 
for 2 min at highest frequency (30 Hertz). The following primers were used: UGV-2 and -3 S 
segment (Fwd 5’-ATAAGGTCAGGGTATAACTTGG-3’ and Rev 5’-GAACTTGGCATAA 
AAATACAAATGAATG-3’), S5-like S segment (Fwd 5’-GTCAGGATAGAGTCTGGGAGCAT- 
3’ and Rev 5’-TGAACATTCAGAGGGAATTTGGCATC-3’), TSMV-2 S-segment (Fwd 5’- 
CAAGTCTGGATAAAGTCTTGGTGCAT-3’ and Rev 5’-GTAATTGATGACGACAATAGG 
GTCGA-3’), OScV-1 L segment (Fwd 5´- GCACTAAGTGGATCATCAAC-3´ and Rev 5´- 
CATGCAAACCTGTTGCTG-3´), and OScV-2 L segment (Fwd 5´- GCACTAAGTGGATCATC 
AAC-3´ and Rev 5´-GAACAATGTCATAACTTGCTC-3´); RT-PCR was performed as 
described [1], the amplicons analysed by agarose gel electrophoresis, and the bands visualised 
by GelRed Nucleic Acid Gel Stain (BIOTIUM) under UV-light with the UVP BioDoc-It Imag- 
ing System (Thermo Fisher Scientific). The GeneRuler 100 bp DNA ladder (Thermo Fisher 
Scientific) served as the marker. 
 
Western blot (WB) 
We used UGV-1 virions concentrated by ultracentrifugation through a sucrose cushion, pre- 
pared as described in [7], as the antigen in WB. We did the WBs with plasma samples as 
described in [14], but blocked the nitrocellulose membranes for 3–4 h instead of 30 min at 
room temperature. We used snake plasma at 1:200 dilution, and the affinity purified unlabelled 
anti-IgM and anti-IgY antibodies [14] at respective dilutions of 1:500 and 1:1000. We evalu- 
ated the results recorded using the Odyssey CLx Infrared Imaging System (LI-COR Biosci- 
ences) as negative (–), weakly positive (+), moderately positive (++), and strongly positive 
(+++) according to the signal intensity. 
 
Enzyme-linked immunosorbent assay (ELISA) 
We set up an ELISA to measure the IgM and IgY levels in the plasma samples using concen- 
trated UGV-1 virions (inactivated with 1% Triton X-100 [Fluka BioChemika]), and recombi- 
nant UHV-1 NP and UHV-1 NP-C (described in [61]) as the antigens. We diluted the 
antigens (UGV-1 at 1:400, UHV-1 NP and UHV-1 NP-C at 2 μg/ml) in 0.05M carbonate 
buffer, pH 9.6, and used 100 μl/well to coat Nunc Microplate Immuno Polysorp (Thermo Sci- 
entific) plates by overnight incubation on an orbital shaker at 4˚C. After coating, we used 1% 
BSA in PBS (150 μl/well) for blocking (2 h at 37˚C), washed once with TBS-T (TBS + 0.05% 
Tween-20) prior to incubation (1 h at 37˚C) with the plasma samples diluted (1:200 used for 
UHV-1 NP-C, and 1:400 for UHV-1 NP and UGV-1) in 0.25% BSA/PBS. After four TBS-T 
washes, we incubated (45 min at 37˚C) the plates with 100 μl/well of horseradish peroxidase 
(HRP) labelled anti-boa IgM or anti-boa IgY antibodies, described in [14], diluted 1:2000 in 
0.25% BSA/PBS, washed four times with TBS-T, incubated (20 min at RT) with TMB Substrate 
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Solution (Thermo Scientific) 100 μl/well, terminated the reaction by addition of 1M H2SO4 
50 μl/well, and read the results (OD at 450 nm) with a BioTek Synergy HT Multi-Mode Micro- 
plate Reader. 
We performed change point analysis utilising the changepoint v.2.2.2 package (https://rdrr. 
io/cran/changepoint/) in R to set the cut-off values (separately for IgM and IgY and for each 
antigen) for distinguishing positive and negative ELISA results. Briefly, we used the cpt.mean- 
var function with the AMOC method on the ELISA data arranged in ascending order. We set 
the cut-offs (UHV NP IgY = 0.31; UHV NP IgM = 0.35; UGV-1 IgY = 0.27; UGV-1 IgM = 
0.48 ; UHV NP-C IgY = 0.47; and UHV NP-C IgM = 0.37) just above the detected change 
point, so that the value at change point was considered negative. 
 
Statistical analysis 
We performed data analysis using Stata Statistical Software: Release 13. College Station, TX: 
StataCorp LP. The analysis examined possible associations between test results and population 
parameters using univariate and multivariable analysis. For data that were not normally dis- 
tributed, we utilised non-parametric tests. Given the nature of the investigation and the study 
population, the analysis is predominantly descriptive. Sensitivity and specificity calculations 
for the different tests were used as indicative since the study was not designed for the purpose. 
Cohen’s kappa (κ) and weighted kappa κ (w) served to examine the agreement between tests 
with binary or ordinal data [42]. 
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